Finance

Lists
Why is NBP down 2.60%?
Dive Deeper
NBP:NASDAQ
NovaBridge Biosciences
$0.81
-2.60%
(-0.022) 1D
Nov 13, 2:21:31 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBP...
Open
$0.82
High
$0.82
Low
$0.78
Mkt. cap
95.16M
Avg. vol.
469.51K
Volume
525.78K
52-wk high
$5.17
52-wk low
$0.78
EPS
-$0.66
Beta
1.71
Shares outstanding
115.65M
No. of employees
30
Open
$0.82
High
$0.82
Low
$0.78
Mkt. cap
95.16M
Avg. vol.
469.51K
Volume
525.78K
52-wk high
$5.17
52-wk low
$0.78
EPS
-$0.66
Beta
1.71
Shares outstanding
115.65M
No. of employees
30
News stories
From web sources and news partners
About NovaBridge Biosciences
CEO-
Employees30
Founded2014
HeadquartersRockville, Maryland, United States
SectorHealth Care
IndustryBiotechnology
Websitenovabridge.com
Analyst ratings
Based on 1 analyst giving stock ratings to NBP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NBP in the last 3 months
Highest
Current $0.81
$9.00 (+1,013.31%)
Average
$9.00 (+1,013.31%)
Lowest
$9.00 (+1,013.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$9.00
+1,013.3%
10/30/2026
Justin Zelin
BTIG
Buy
Reiterated
$9.00
+1,013.3%
01/06/2026
Daina Graybosch
Leerink Partners
Buy
Initiated
$9.00
+1,013.3%
10/06/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.18M
55.66M
7.16M
7.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.81M
17.24M
13.21M
13.21M
Operating expense
8.99M
72.90M
20.37M
20.37M
Total operating expenses
8.99M
72.90M
20.37M
20.37M
Operating income
-8.99M
-72.90M
-20.37M
-20.37M
Other non operating income
31.00K
-11.00K
20.50K
20.50K
EBT including unusual items
-6.83M
-72.86M
-18.93M
-18.93M
EBT excluding unusual items
-6.81M
-71.12M
-19.10M
-19.10M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.83M
-72.86M
-18.93M
-18.93M
Net profit margin
-
-
-
-
Earnings per share
-0.06
-0.31
-
-
Interest and investment income
2.15M
1.79M
1.17M
1.17M
Interest expense
-
-
-
-
Net interest expenses
2.15M
1.79M
1.17M
1.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.97M
-72.88M
-20.34M
-20.34M
Gain or loss from assets sale
-
-
14.00K
14.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps